BTG plc (LON:BTG) had its price objective boosted by JPMorgan Chase & Co. from GBX 790 ($9.78) to GBX 830 ($10.27) in a report released on Friday morning. The brokerage currently has a neutral rating on the stock.
A number of other analysts have also issued reports on the stock. Stifel Nicolaus restated a hold rating and set a GBX 640 ($7.92) target price on shares of BTG plc in a research report on Thursday, October 6th. Numis Securities Ltd reiterated a hold rating and issued a GBX 737 ($9.12) price target on shares of BTG plc in a report on Thursday, October 6th. Deutsche Bank AG reiterated a buy rating on shares of BTG plc in a report on Thursday, September 8th. Finally, Jefferies Group reiterated a buy rating and issued a GBX 860 ($10.64) price target on shares of BTG plc in a report on Friday, July 15th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of Buy and a consensus price target of GBX 799.57 ($9.90).
Shares of BTG plc (LON:BTG) opened at 701.00 on Friday. BTG plc has a 52-week low of GBX 504.00 and a 52-week high of GBX 739.50. The stock’s market cap is GBX 2.68 billion. The stock’s 50 day moving average price is GBX 633.03 and its 200-day moving average price is GBX 642.16.
In other news, insider Soderstrom,Rolf sold 74,327 shares of the firm’s stock in a transaction on Thursday, July 21st. The shares were sold at an average price of GBX 676 ($8.37), for a total value of £502,450.52 ($621,844.70).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.